Patents by Inventor Annette Eichardt

Annette Eichardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7192942
    Abstract: The process for making crystals of a 11 ?-benzaldoxim-estra-4,9-diene derivative having an average particle size of from 3 ?m to 25 ?m and a maximum particle size of 100 ?m, includes subjecting a supersaturated solution containing a special 11?-benzaldoxim-estra-4,9-diene derivative of formula (I) to a wet milling by a wet milling apparatus while crystallizing, In order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described and are part of the invention.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: March 20, 2007
    Assignee: Schering AG
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Patent number: 7148212
    Abstract: The process for making steroid crystals having a predetermined average particle size of from 1 ?m to 25 ?m and a maximum particle size that does not exceed a predetermined maximum value of 100 ?m, includes subjecting a supersaturated solution containing a steroid to a wet milling by wet milling apparatus while crystallizing, in order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: December 12, 2006
    Assignee: Schering AG
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Publication number: 20030225050
    Abstract: The process for making crystals of a 11&bgr;-benzaldoxim-estra-4,9-diene derivative having a predetermined average particle size in a predetermined size range and a maximum particle size that does not exceed a predetermined maximum value, includes subjecting a supersaturated solution containing a special 11&bgr;-benzaldoxim-estra-4,9-diene derivative of formula (I) to a wet milling by a wet milling apparatus while crystallizing, in order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described.
    Type: Application
    Filed: April 17, 2003
    Publication date: December 4, 2003
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Publication number: 20030216360
    Abstract: The process for making steroid crystals having a predetermined average particle size in a predetermined size range and a maximum particle size that does not exceed a predetermined maximum value, includes subjecting a supersaturated solution containing a steroid to a wet milling by a wet milling apparatus while crystallizing, in order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described.
    Type: Application
    Filed: April 17, 2003
    Publication date: November 20, 2003
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Publication number: 20030215516
    Abstract: The process for making crystals of a medicinally effective ingredient having a predetermined average particle size in a predetermined size range and a maximum particle size that does not exceed a predetermined maximum value, includes subjecting a supersaturated solution containing the medicinally effective ingredient to a wet milling by a wet milling apparatus while crystallizing, in order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described.
    Type: Application
    Filed: April 17, 2003
    Publication date: November 20, 2003
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Publication number: 20030215517
    Abstract: The process for making crystals of an adjuvant substance for pharmaceutical compositions, which have a predetermined average particle size in a predetermined size range and a maximum particle size that does not exceed a predetermined maximum value, includes subjecting a supersaturated solution containing the adjuvant substance to a wet milling by a wet milling apparatus while crystallizing, in order to obtain a primary particle suspension. Crystals obtained according to this process and pharmaceutical preparations containing them are also described.
    Type: Application
    Filed: April 17, 2003
    Publication date: November 20, 2003
    Inventors: Detlef Grawe, Hagen Gerecke, Peter Hoesel, Annette Eichardt, Sabine Gliesing, Uwe Mueller
  • Patent number: 6117450
    Abstract: The method of making a solid drug with controlled effective ingredient delivery for oral administration includes selecting a predetermined number of at least three of four compressed compositions containing an effective ingredient or effective ingredient combination defined by their release profile of effective ingredient and/or effective ingredient combination. The solid drug or medicinal preparation is formed according to known methods requiring only comparatively small apparatus expense and minimal time. Perorally administered solid drugs are made by this process which can provide widely varying pharmaceutically-required release profiles of effective ingredients or effective ingredient combinations, for example delayed release, uniformly maintained release or pulsatile release adjusted to fit a special rhythm.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: September 12, 2000
    Assignee: JENAPHARM GmbH & Co. KG
    Inventors: Michael Dittgen, Sabine Fricke, Carsten Timpe, Hagen Gerecke, Annette Eichardt